PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Servei de Reumatologia.\', \'Servei de Medicina Interna.\', \'Servei de Pneumologia.\', \'Servei de Farmàcia Hospitalària.\', \'Unitat de Malalties Infeccioses.\', \'Servei Immunologia, Hospital de la Santa Creu i Sant Pau, Barcelona, Universitat Autònoma de Barcelona (UAB), Barcelona, Catalonia, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1097/MD.0000000000025923
?:hasPublicationType
?:journal
  • Medicine
is ?:pmid of
?:pmid
?:pmid
  • 34106658
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.105
?:rankingScore_hIndex
  • 4
is ?:relation_isRelatedTo_publication of
?:title
  • Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all